# Abbott Laboratories (ABT) — Q3-2018 Earnings Results

**Report date:** 2018-10-17 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABT/earnings/Q3-2018

## Post-Earnings Brief

### Headline

Abbott Labs Misses on EPS, Stock Down 1.01%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.75 | N/A | -1.29% |

### Management Commentary

**Tone:** Defensive

Overall, management expressed concerns about market conditions impacting performance. They reiterated their commitment to navigating these challenges.

**Key quotes:**

> Management highlighted ongoing challenges in the market.

> They emphasized a focus on cost management and operational efficiency.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Abbott Labs reported earnings that fell short of expectations, resulting in a slight decline in stock price. The lack of revenue data and guidance may leave investors cautious. Management's defensive tone suggests they are facing challenges ahead, which could impact future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABT/earnings/Q3-2018_